Logo image of ZVRA

ZEVRA THERAPEUTICS INC (ZVRA) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:ZVRA - US4884452065 - Common Stock

8.4 USD
-0.05 (-0.59%)
Last: 12/11/2025, 2:40:48 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
ZVRA revenue by date.ZVRA revenue by date.
10.46M
-63.49%
27.461M
162.53%
23.612M
-14.02%
102.3M
333.25%
147.01M
43.70%
226.82M
54.29%
305.16M
34.54%
359.98M
17.96%
401.68M
11.58%
431.39M
7.40%
394.72M
-8.50%
EBITDA
YoY % growth
ZVRA ebitda by date.ZVRA ebitda by date.
-23.91M
-399.25%
-48.598M
-103.25%
-80.614M
-65.88%
-74.664M
7.38%
35.802M
147.95%
69.258M
93.45%
124.54M
79.82%
190.64M
53.08%
220.32M
15.57%
251.43M
14.12%
226.95M
-9.74%
EBIT
YoY % growth
ZVRA ebit by date.ZVRA ebit by date.
-24.85M
-421.47%
-49.604M
-99.61%
-87.003M
-75.40%
-67.231M
22.73%
39.798M
159.20%
107.1M
169.11%
172.4M
60.97%
219.56M
27.35%
256.95M
17.03%
289.23M
12.56%
285.49M
-1.29%
Operating Margin
ZVRA operating margin by date.ZVRA operating margin by date.
-237.57%-180.63%-368.47%-65.72%27.07%47.22%56.49%60.99%63.97%67.05%72.33%
EPS
YoY % growth
ZVRA eps by date.ZVRA eps by date.
-0.69
-50.00%
-1.29
-86.96%
-2.26
-75.19%
1.31
157.77%
0.57
-56.45%
1.64
188.02%
2.69
64.10%
3.31
23.06%
3.69
11.72%
3.86
4.42%
3.57
-7.40%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
0.04
106.28%
0.11
276.80%
0.15
-87.86%
0.17
1,834.00%
0.18
323.53%
0.23
121.15%
0.30
101.39%
0.35
100.00%
0.40
116.67%
Revenue
Q2Q % growth
28.627M
137.71%
32.896M
61.25%
36.178M
39.79%
38.943M
49.42%
46.215M
61.44%
50.082M
52.24%
54.346M
50.22%
58.15M
49.32%
62.23M
34.65%
EBITDA
Q2Q % growth
714K
107.91%
6.936M
286.80%
8.16M
190.38%
8.874M
13.26%
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
4.107M
126.64%
7.11M
232.60%
9.95M
180.70%
11.362M
174.25%
18.272M
344.90%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.01
98.55%
-0.040.0371.99%
Q2 2025
Q2Q % growth
1.21
352.08%
1.53-0.32-20.80%
Q1 2025
Q2Q % growth
-0.06
85.00%
-0.190.1368.49%
Q4 2024
Q2Q % growth
-0.69
-72.50%
-0.41-0.28-67.34%
Q3 2024
Q2Q % growth
-0.69
-72.50%
-0.43-0.26-60.59%
Q2 2024
Q2Q % growth
-0.48
-220.00%
-0.44-0.04-8.43%
Q1 2024
Q2Q % growth
-0.40
-17.65%
-0.490.0917.96%
Q4 2023
Q2Q % growth
-0.40
-53.85%
-0.27-0.13-46.15%
Q3 2023
Q2Q % growth
-0.40
-110.53%
-0.30-0.10-31.82%
Q2 2023
Q2Q % growth
-0.15
21.05%
-0.350.2057.17%
Q1 2023
Q2Q % growth
-0.34
-580.00%
-0.24-0.10-43.37%
Q4 2022
Q2Q % growth
-0.26
-225.00%
-0.18-0.08-47.06%
Q3 2022
Q2Q % growth
-0.19
-280.00%
-0.13-0.06-43.29%
Q2 2022
Q2Q % growth
-0.19
-190.48%
-0.12-0.07-55.23%
Q1 2022
Q2Q % growth
-0.05
90.74%
-0.060.0110.87%
Q4 2021
Q2Q % growth
-0.08
92.52%
-0.080.00-4.58%
Q3 2021
Q2Q % growth
-0.05
92.19%
-0.080.0334.64%
Q2 2021
Q2Q % growth
0.21
31.25%
0.23-0.02-8.50%
Q1 2021
Q2Q % growth
-0.54
69.32%
-0.17-0.37-211.42%
Q4 2020
Q2Q % growth
-1.07
-568.75%
-0.65-0.42-63.91%
Q3 2020
Q2Q % growth
-0.64
-166.67%
-0.820.1821.57%
Q2 2020
Q2Q % growth
0.16
103.03%
0.000.16%
Q1 2020
Q2Q % growth
-1.76
76.09%
0.16-1.92-1,178.43%
Q4 2019
Q2Q % growth
-0.16 -1.391.2388.47%
Q3 2019
Q2Q % growth
0.96 -3.054.01131.51%
Q2 2019
Q2Q % growth
-5.28 -6.941.6623.88%
Q1 2019
Q2Q % growth
-7.36 -7.510.151.96%
ZVRA Yearly EPS VS EstimatesZVRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -20 -40 -60 -80 -100
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
26.063M
605.36%
27.161M-1.098M-4.04%
Q2 2025
Q2Q % growth
25.881M
481.73%
22.986M2.895M12.59%
Q1 2025
Q2Q % growth
20.401M
495.65%
17.297M3.104M17.95%
Q4 2024
Q2Q % growth
12.043M
-8.88%
9.104M2.939M32.28%
Q3 2024
Q2Q % growth
3.695M
27.63%
4.966M-1.271M-25.59%
Q2 2024
Q2Q % growth
4.449M
-47.47%
4.443M6K0.14%
Q1 2024
Q2Q % growth
3.425M
18.96%
3.839M-414K-10.78%
Q4 2023
Q2Q % growth
13.217M
469.70%
11.973M1.244M10.39%
Q3 2023
Q2Q % growth
2.895M
0.87%
3.447M-552K-16.01%
Q2 2023
Q2Q % growth
8.47M
551.54%
3.094M5.376M173.76%
Q1 2023
Q2Q % growth
2.879M
-27.48%
2.708M171K6.31%
Q4 2022
Q2Q % growth
2.32M
-10.08%
3.264M-944K-28.92%
Q3 2022
Q2Q % growth
2.87M
45.69%
3.264M-394K-12.07%
Q2 2022
Q2Q % growth
1.3M
-89.16%
1.836M-536K-29.19%
Q1 2022
Q2Q % growth
3.97M
-67.24%
3.126M844K27.00%
Q4 2021
Q2Q % growth
2.58M
8.86%
2.28M300K13.16%
Q3 2021
Q2Q % growth
1.97M
2.07%
2.228M-258K-11.58%
Q2 2021
Q2Q % growth
11.99M
73.52%
12.342M-352K-2.85%
Q1 2021
Q2Q % growth
12.12M
479.90%
2.142M9.978M465.83%
Q4 2020
Q2Q % growth
2.37M
71.74%
2.04M330K16.18%
Q3 2020
Q2Q % growth
1.93M
-83.16%
1.938M-8K-0.41%
Q2 2020
Q2Q % growth
6.91M 6.885M25K0.36%
Q1 2020
Q2Q % growth
2.09M 5.916M-3.826M-64.67%
Q4 2019
Q2Q % growth
1.38M 5.66M-4.28M-75.62%
Q3 2019
Q2Q % growth
11.46M 2.992M8.468M283.02%
ZVRA Yearly Revenue VS EstimatesZVRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS466.67% 187.18% 6.44% 88.7%
Revenue0.01% 0.65% -0.73% 0.86%